Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patientsLJUNGBERG, B; NILSSON-EHLE, I.European journal of clinical pharmacology. 1988, Vol 34, Num 2, pp 173-178, issn 0031-6970Article

Pharmacokinetics of antimicrobial agents in the elderlyLJUNGBERG, B; NILSSON-EHLE, I.Reviews of infectious diseases. 1987, Vol 9, Num 2, pp 250-264, issn 0162-0886Article

Abdominal aortitis and infected aneurysms due to salmonellaLJUNGBERG, B; BRACONIER, J. H.Scandinavian journal of infectious diseases. 1986, Vol 18, Num 5, pp 401-406, issn 0036-5548Article

Advancing age and acute infection influence the kinetics of ceftazidimeLJUNGBERG, B; NILSSON-EHLE, I.Scandinavian journal of infectious diseases. 1989, Vol 21, Num 3, pp 327-332, issn 0036-5548Article

Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill malesLJUNGBERG, B; NILSSON-EHLE, I.European journal of clinical pharmacology. 1988, Vol 34, Num 2, pp 179-186, issn 0031-6970Article

Value of DNA analysis for treatment of renal cell carcinomaLJUNGBERG, B; ROOS, G.European urology. 1990, Vol 18, pp 31-32, issn 0302-2838, 2 p., suppl. 2Article

Pharmacokinetics of intravenous ciprofloxacin at three different dosesLJUNGBERG, B; NILSSON-EHLE, I.Journal of antimicrobial chemotherapy (Print). 1988, Vol 22, Num 5, pp 715-720, issn 0305-7453Article

DNA content in renal cell carcinoma and its clinical significanceROOS, G; LJUNGBERG, B.European urology. 1990, Vol 18, pp 29-30, issn 0302-2838, 2 p., suppl. 2Article

Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinomaLJUNGBERG, B; GRANKVIST, K; RASMUSON, T et al.European journal of cancer (1990). 1997, Vol 33, Num 11, pp 1794-1798, issn 0959-8049Article

Serum acute phase reactants and prognosis in renal cell carcinomaLJUNGBERG, B; GRANKVIST, K; RASMUSSON, T et al.Cancer. 1995, Vol 76, Num 8, pp 1435-1439, issn 0008-543XArticle

Telomere shortening in renal cell carcinomaMEHLE, C; LJUNGBERG, B; ROOS, G et al.Cancer research (Baltimore). 1994, Vol 54, Num 1, pp 236-241, issn 0008-5472Article

Venous invasion in renal cell carcinoma: a correlative clinical and radiologic studyHIETALA, S.-O; EKELUND, L; LJUNGBERG, B et al.Urologic radiology. 1988, Vol 9, Num 4, pp 210-216, issn 0171-1091Article

DNA content and prognosis in renal cell carcinoma: a comparison between primary tumors and metastasesLJUNGBERG, B; STENLING, R; ROOS, G et al.Cancer. 1986, Vol 57, Num 12, pp 2346-2350, issn 0008-543XArticle

DNA content in renal cell carcinoma. A comparison between flow and static cytometric methodsROOS, G; STENLING, R; LJUNGBERG, B et al.Scandinavian journal of urology and nephrology. 1986, Vol 20, Num 4, pp 295-300, issn 0036-5599Article

Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarrayHEDBERG, Y; LJUNGBERG, B; ROOS, G et al.British journal of cancer. 2003, Vol 88, Num 9, pp 1417-1423, issn 0007-0920, 7 p.Article

Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinomaRASMUSON, T; GRANKVIST, K; JACOBSEN, J et al.European journal of cancer (1990). 2001, Vol 37, Num 17, pp 2199-2203, issn 0959-8049Article

Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinomaRASMUSON, T; GRANKVIST, K; LJUNGBERG, B et al.British journal of cancer. 1997, Vol 75, Num 11, pp 1674-1677, issn 0007-0920Article

Proliferating cell nuclear antigen expression in renal cell carcinoma prognostic implicationsLARSSON, P; ROOS, G; STENLING, R et al.Scandinavian journal of urology and nephrology. 1996, Vol 30, Num 6, pp 445-450, issn 0036-5599Article

Accuracy of clinical staging in non-seminomatous testicular cancer : a single centre experience of retroperitoneal lymph node dissectionCARLSSON-FERRELLY, E; BOQUIST, L; LJUNGBERG, B et al.Scandinavian journal of urology and nephrology. 1995, Vol 29, Num 4, pp 501-506, issn 0036-5599Article

Multiple renal masses in patients with renal cell carcinoma : diagnostic pitfalls and surgical implicationsHOLMBERG, G; HIETALA, S.-O; LJUNGBERG, B et al.Scandinavian journal of urology and nephrology. 1992, Vol 26, Num 4, pp 367-371, issn 0036-5599Article

Metronidazole: pharmacokinetic observations in severely ill patientsLJUNGBERG, B; NILSSON-EHLE, I; URSING, B et al.Journal of antimicrobial chemotherapy (Print). 1984, Vol 14, Num 3, pp 275-283, issn 0305-7453Article

Vascular endothelial growth factor as prognostic factor in renal cell carcinomaJACOBSEN, J; RASMUSON, T; GRANKVIST, K et al.The Journal of urology. 2000, Vol 163, Num 1, pp 343-347, issn 0022-5347Article

Serum γ-enolase and prognosis of patients with renal cell carcinomaRASMUSON, T; GRANKVIST, K; LJUNGBERG, B et al.Cancer. 1993, Vol 72, Num 4, pp 1324-1328, issn 0008-543XArticle

Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinomaLJUNGBERG, B; LARSSON, P; STENLING, R et al.The Journal of urology. 1991, Vol 146, Num 3, pp 697-699, issn 0022-5347Article

Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinomaTOMIC, R; LJUNGBERG, B; DAMBER, J.-E et al.Scandinavian journal of urology and nephrology. 1988, Vol 22, Num 1, pp 15-18, issn 0036-5599Article